MLI Performance Autocall (MLI 2015 - 14)
This product is not available for subscription
The Market Linked Investment (MLI) is a 3 year Deferred Purchase Agreement product which is linked to the performance of shares in four listed companies: Bayer AG (“BAYN GY”); Pfizer Inc. (“PFE UN”); AstraZeneca PLC (“AZN LN”); and Bristol-Myers Squibb Company (“BMY UN”), each a Reference Asset, and together the Reference Assets. The MLI offers a potential income payment or a potential growth payment which is linked to the performance of the Worst Performing Reference Asset throughout the term of the investment. The MLI includes an Autocall event feature, an Early Maturity feature and a Knock-In Event feature which may result in the Investment terminating before the Maturity Date, or the loss of some or all of your investment amount.
Investors should read and understand the contents of the relevant Product Disclosure Statement, including the risks of investing in the MLI, and seek any relevant independent advice before making any investment decision.
For further information on structured financial products contact the Citigroup Structured Products Service Centre.